SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amanta Healthcare - Quaterly Results

27 Sep 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 653.07 millions against Rs. 680.96 millions recorded during the year-ago period.The Total Profit for the quarter ended June 2025 of Rs. 35.08 millions grew from Rs.-3.63 millionsOperating profit for the quarter ended June 2025 rose to 158.55 millions as compared to 135.42 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202506 202406 % Var
Sales 653.07 680.96 -4.10 653.07 680.96 -4.10 653.07 680.96 -4.10
Other Income 9.61 1.46 558.22 9.61 1.46 558.22 9.61 1.46 558.22
PBIDT 158.55 135.42 17.08 158.55 135.42 17.08 158.55 135.42 17.08
Interest 62.87 94.47 -33.45 62.87 94.47 -33.45 62.87 94.47 -33.45
PBDT 95.68 40.95 133.65 95.68 40.95 133.65 95.68 40.95 133.65
Depreciation 46.41 46.00 0.89 46.41 46.00 0.89 46.41 46.00 0.89
PBT 49.27 -5.05 -1075.64 49.27 -5.05 -1075.64 49.27 -5.05 -1075.64
TAX 14.19 -1.42 -1099.30 14.19 -1.42 -1099.30 14.19 -1.42 -1099.30
Deferred Tax -2.33 -1.42 64.08 -2.33 -1.42 64.08 -2.33 -1.42 64.08
PAT 35.08 -3.63 -1066.39 35.08 -3.63 -1066.39 35.08 -3.63 -1066.39
Equity 288.29 282.70 1.98 288.29 282.70 1.98 288.29 282.70 1.98
PBIDTM(%) 24.28 19.89 22.08 24.28 19.89 22.08 24.28 19.89 22.08

Amanta Healthcare Share Price

130.37 1.47 (1.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×